Aug 2026· Nan fang yi ke da xue xue bao = Journal of Southern Medical University· Vol 46 8, pp.
1926-1935
· 0 citations
Medicine
TL;DR
Negativibacillus massiliensis is likely associated with an increased risk of AD, and v-VLDL FC/TL may partially mediate this association, suggesting their potential as targets for AD prevention and treatment.
Genetic evidence is provided that gut microbiota influence CKD risk partially through circulating metabolites, highlighting the gut microbiota–metabolite–CKD axis as a potential therapeutic target.
The MR study supports a causal relationship between specific GM groups and the risk of CAHD, highlighting that cholesterol traits are not merely outcomes associated with the relationship between GM and CAHD, but are important mediating factors.
This study emphasizes the potential central axis of gut microbiota-plasma metabolites-CAS and identifies microbial and plasma metabolite candidates that may serve as targets for early prevention and intervention of CAS.
Genetic evidence linking inflammatory proteins to MS pathogenesis was uncovered, offering clues for novel therapeutic targets for this condition and strengthening the biological plausibility of inflammation-driven disease mechanisms.
Run-Yang Xu, Ancha Baranova, Hong-Bao Cao et al.· Current Neurovascular Resear...· 0 citations
This study provides genetic evidence supporting a bidirectional causal relationship between specific saliva and gut microbiota and bone neoplasm-related phenotypes and identifies several microbial taxa as potential candidates for future biomarker development and therapeutic investigation in bone neoplasm-related phenot...
